Chapter Update Summary

7/5/2018

Updated with the latest data on sexual risk behaviors among adolescents in the United States

7/5/2018

New interim recommendations from DHHS regarding dolutegravir use in adults and adolescents with HIV who are pregnant or of childbearing potential

2/13/2018

10/29/2015

7/2/2014

10/14/2013

3/13/2013

11/1/2011

11/17/2010

Updated to include:
  • Expanded indication of tenofovir to include treatment of patients aged 12 to younger than 18 years
  • Updates from the 2010 pediatric guidelines